September 12, 2025

PureTech Health plc (PRTC) Stock Analysis: Unveiling a Potential 182% Upside for Patient Investors

PureTech Health plc (NASDAQ: PRTC) is capturing the attention of investors with its compelling prospects in the biotechnology sector. With a market capitalization of $394.19 million, this U.S.-based healthcare entity..

MBX Biosciences, Inc. (MBX) Stock Analysis: Unveiling a Biotech Gem with 279.80% Potential Upside

MBX Biosciences, Inc. (NASDAQ: MBX) is capturing the attention of investors with its ambitious pipeline and extraordinary analyst ratings suggesting a staggering potential upside of nearly 280%. As a clinical-stage..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Investors Eye 157% Potential Upside with Biotech Innovator

For investors keen on the biotechnology sector, Praxis Precision Medicines, Inc (PRAX) presents an intriguing opportunity. This clinical-stage biopharmaceutical company is focused on developing therapies for central nervous system disorders..

Emergent BioSolutions Inc. (EBS) Stock Analysis: A Closer Look at a Potential 64% Upside

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, operates within the specialized niche of drug manufacturing, focusing on preparedness and response solutions for public health threats...

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: 113.82% Potential Upside Sparks Investor Interest

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is catching the attention of investors with its significant potential upside of 113.82%, according to analyst ratings. This..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 123.88% Potential Upside

Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, is drawing significant attention from investors with a striking potential upside of 123.88%. This clinical-stage biopharmaceutical company, headquartered..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Castle Biosciences (CSTL) Stock Analysis: A 56.59% Potential Upside in the Healthcare Diagnostics Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) is capturing investor attention with its promising potential upside of 56.59%, as indicated by analyst ratings. Operating within the healthcare sector, this US-based molecular diagnostics..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Gem with a 230% Upside Potential

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector, with its innovative approach to drug discovery in targeted oncology and genetic diseases. As a clinical-stage precision medicines..

Immunome, Inc. (IMNM) Stock Analysis: Exploring the 145.87% Potential Upside

Immunome, Inc. (NASDAQ: IMNM), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to targeted cancer therapies. With a market capitalization of $842.6 million,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Focus on Innovation

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, presents a mixed bag of opportunities and challenges for investors. Headquartered in Alpharetta, Georgia,..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a Potential 75% Upside in the Medical Devices Sector

Investors seeking opportunities in the healthcare sector might find Bioventus Inc. (NASDAQ: BVS), a promising candidate. This medical device company is dedicated to alleviating pain and enhancing musculoskeletal therapies, both..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Navigating a 60.78% Potential Upside Amid Transformative Immunology Advances

Zenas BioPharma, Inc. (ZBIO) is drawing attention from investors with its impressive 60.78% potential upside, driven by its pioneering work in transformative immunology-based therapies. As a clinical-stage biopharmaceutical company, Zenas..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring a 136% Upside Potential with Innovative PROTAC Technology

Arvinas, Inc. (NASDAQ: ARVN) stands out in the biotechnology sector with its pioneering approach to drug development, leveraging its proprietary PROTAC technology to tackle challenging diseases. Despite facing a turbulent..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

Investors eyeing the healthcare sector might find Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) a compelling opportunity, given its potential 17.19% upside based on current analyst targets. With a market capitalization..

Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating a High RSI Amidst Biotech Innovations

Tourmaline Bio, Inc. (NASDAQ: TRML) has become a notable player in the biotechnology sector with its innovative approach to treating immune and inflammatory diseases. The company, with a market capitalization..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Eyeing a Massive 342% Upside with Strong Analyst Support

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of savvy investors, with analysts forecasting a remarkable potential upside of 342.32%. Operating in the dynamic biotechnology industry, the company is..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Uncovering a Potential 240% Upside in the Biotechnology Sector

Bicycle Therapeutics plc (NASDAQ: BCYC), a United Kingdom-based clinical-stage pharmaceutical company, is capturing the attention of investors with its unique approach to drug development. Specializing in the creation of Bicycle..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a 33% Potential Upside in the Volatile Medical Devices Sector

Investors with a keen eye on the healthcare sector might find Standard BioTools Inc. (NASDAQ: LAB) intriguing, especially with its 33.46% potential upside. The company, headquartered in South San Francisco,..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating a Challenging Market with 11.82% Upside Potential

Owens & Minor, Inc. (NYSE: OMI), a longstanding player in the healthcare sector with roots dating back to 1882, is currently navigating a challenging landscape marked by significant disparities in..

Search

Funds

September 12, 2025

Search

Funds

September 12, 2025

FTSE 100

Funds